###begin article-title 0
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 65 69 <span type="species:ncbi:10090">mice</span>
In the present study, we used tumor necrosis factor-R1 knock out mice (TNF-alphaR1KO) to understand the roles of TNF-alpha on epithelial function in models of carrageenan-induced acute lung inflammation. In order to elucidate whether the observed anti-inflammatory status is related to the inhibition of TNF-alpha, we also investigated the effect of etanercept, a TNF-alpha soluble receptor construct, on lung TJ function. Pharmacological and genetic TNF-alpha inhibition significantly reduced the degree of (1) TNF-alpha production in pleural exudates and in the lung tissues, (2) the inflammatory cell infiltration in the pleural cavity as well as in the lung tissues (evaluated by MPO activity), (3) the alteration of ZO-1, Claudin-2, Claudin-4, Claudin-5 and beta-catenin (immunohistochemistry) and (4) apoptosis (TUNEL staining, Bax, Bcl-2 expression). Taken together, our results demonstrate that inhibition of TNF-alpha reduces the tight junction permeability in the lung tissues associated with acute lung inflammation, suggesting a possible role of TNF-alpha on lung barrier dysfunction.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
An important consequence of acute lung injury is the disruption of the paracellular alveolar permeability barrier [1]. The permeability barrier in terminal airspaces of the lung is due in large part to tight junctions between alveolar epithelial cells, which regulate the flow of molecules between apical and basolateral compartments [2,3]. Transmembrane proteins in the occludin and claudin families are the major transmembrane structural elements of tight junctions [4,5]. It has previously been shown that alveolar epithelial cells express occludin and zona occludens 1 (ZO-1) as part of the tight junction complex [6,7]. In addition to these components, the importance of claudins in pulmonary barrier function is underscored by the viability of occludin-deficient mice [8].
###end p 4
###begin p 5
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 975 977 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1298 1300 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1584 1586 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1665 1667 1641 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1709 1711 1685 1687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1789 1791 1765 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Moreover, is well known that airway epithelial cells perform many important functions, serving as an interface between environmental stimuli and the lung parenchyma. Normally the lower airways are pristine, free of bacterial flora or inflammatory cells, and are well protected by several layers of defenses including antimicrobial peptides, mucin, and ciliary action. There is a brisk epithelial response to airway injury caused by many different mechanisms [9,10]. Acute lung inflammatory response is also is associated to epithelial cytokine expression [11] as well as to the expression of the signaling cascade leading to apoptosis (programmed cell death). Activation of epithelial proinflammatory signaling cascades is mediated by tumor Necrosis Factor (TNF)-alpha a prototypic member of a cytokine family which regulates essential biologic functions (e.g. cell differentiation, proliferation, survival, apoptosis) and a broad spectrum of responses to stress and injury [12]. It is primarily produced by immune cells such as monocytes and macrophages, but it can also be released by many other cell types, including acinar cells. Membrane bound or soluble TNF-alpha interacts with two different surface receptors, TNF-alpha receptor 1 (TNFR1), or p55, and TNF-alpha receptor 2 (TNFR2), or p75 [13]. Although the extracellular domains of TNFR1 and TNFR2 are homologous and manifest similar affinity for TNF-alpha, the cytoplasmic regions of the two receptors are distinct and mediate different downstream events. Although most cell lines and primary tissues express both isoforms [14], most of the biological activities of TNF-alpha are mediated through TNF-R1 [15]. TNF-R2 is a poor inducer of apoptosis [16] and binding affinities of soluble TNF-a are significantly higher to TNF-R1 [15].
###end p 5
###begin p 6
###xml 498 500 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
After exposure to TNF-alpha, target cells may down-regulate their responsiveness to the cytokine by shedding the receptors into the circulation. A natural mechanism which has been hypothesized to counteract excessive concentrations of circulating TNF-alpha (and the subsequent enhanced surface receptor activation) is the release of soluble receptors. The two soluble receptor forms (sTNFR1 and sTNFR2) have longer half lives than TNF-alpha, and their concentration may reflect TNF-alpha activity [17].
###end p 6
###begin p 7
###xml 201 203 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 204 206 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 399 401 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 402 404 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 939 941 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1255 1257 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1258 1260 1230 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1301 1310 1269 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1332 1340 1300 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1431 1433 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 187 192 <span type="species:ncbi:9606">human</span>
A primary role for TNF-alpha in inflammatory process (e.g. sepsis, endotoxiemic shock and acute pancreatitis) is suggested by several studies conducted upon cell lines, animal models and human beings [18-20]. In inflammation, over-production of TNF-alpha is pivotal in the induction of inflammatory genes, cell death, endothelial up-regulation and in the recruitment and activation of immune cells [21,22]. It has been also regarded as one of the major mediators of systemic progression and tissue damage in severe disease. However, the biologic significance of TNFR shedding is unclear. It could represent a neutralizing mechanism to counteract excessive TNF-alpha activity, but - on the other hand - it has been suggested that in relatively low concentrations sTNFR may serve as carriers to distant organs. Furthermore, sTNFR stabilize TNF-alpha trimeric structure thereby prolonging its half-life and augmenting its biological effects [17]. Etanercept is a fully humanized dimeric soluble form of the p75 TNF receptor that can bind to two TNF-alpha molecules blocking their interaction with cell surface TNFRs and rendering TNF-alpha biologically inactive. TNF-alpha inactivation is one thousand times stronger than inactivation by p75 monomeric TNFR [23,24]. It inhibits the activity of TNF-alpha in vitro and has been examined in vivo for its effects in different animal model systems of inflammatory and autoimmune diseases [25].
###end p 7
###begin p 8
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
In addition, it has been demonstrated that TNF plays a role in the control of epithelial permeability [26-29] as well as in the regulation of pulmonary microvessels endothelium [26]. Moreover, TNF at higher concentrations leads to down-regulation of ZO-1 protein expression and disturbance in junction localization of ZO-1 protein and functional opening of tight junction barrier [29-31]. Base on this evidence, we have hypothesized that increased production of TNF-alpha might lead to structural and functional alterations in pulmonary TJ function in vivo as a result of acute lung inflammation induced by carrageenan in mice. Herein, we demonstrate that acute lung injury is associated with decreased expression and function of several TJ proteins in the lung epithelium. Moreover, we also demonstrate that Etanercept treatment attenuates TJ alteration associated with acute inflammation.
###end p 8
###begin title 9
Methods
###end title 9
###begin title 10
Animals
###end title 10
###begin p 11
###xml 386 396 374 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 582 587 <span type="species:ncbi:9606">Human</span>
Mice (4-5 weeks old, 20-22 g) with a targeted disruption of the TNF-alphaR1 (TNF-alpha R1KO) and wild-type controls (TNF-alphaWT) were purchased from Jackson Laboratories (Charles River, Italy). The study was approved by the University of Messina Review Board for the care of animals. The animals were housed in a controlled environment and provided with standard rodent chow and water ad libitum. Animal care was in compliance with regulations in Italy (D.M. 116192), Europe (O.J. of E.C. L 358/1 12/18/1986) and USA (Animal Welfare Assurance No A5594-01, Department of Health and Human Services, USA).
###end p 11
###begin title 12
Experimental groups for Carrageenin-induced pleurisy
###end title 12
###begin p 13
###xml 60 72 60 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT CAR group</italic>
###xml 130 132 130 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 144 167 144 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAR TNF-&#945;R1KO group</italic>
###xml 249 251 241 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 264 277 256 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT Sham group</italic>
###xml 437 439 428 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 451 475 442 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF-&#945;R1KO Sham group</italic>
###xml 651 653 633 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 664 687 646 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAR WT+Etanercept group</italic>
###xml 865 867 847 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 879 904 861 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT Sham +Etanercept group</italic>
###xml 1078 1080 1060 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
Mice were randomly allocated into the following groups: (i) WT CAR group. WT mice were subjected to carrageenan-induced pleurisy (N = 10); (ii) CAR TNF-alphaR1KO group. TNF-alphaR1KO mice were subjected to subjected to carrageenan-induced pleurisy (N = 10); (iii) WT Sham group. WT mice were subjected to the surgical procedures as the above groups except instead of carrageenan 100 mul of saline solution were administered to the mice (N = 10); (iv) TNF-alphaR1KO Sham group. TNF-alphaR1KO mice were subjected to the surgical procedures as the above groups except that instead of carrageenan 100 mul of saline solution were administered to the mice (N = 10); (v) CAR WT+Etanercept group. Same as CAR WT group except for the administration of Etanercept (5 mg/kg subcutaneously dissolved in saline solution) which was given at 2 h before the carrageenan injection (N = 10); (vi) WT Sham +Etanercept group. Same as the WT Sham group except for the administration of Etanercept (5 mg/kg subcutaneously dissolved in saline solution) which was given at 2 h before saline injection (N = 10);
###end p 13
###begin title 14
Carrageenan-induced pleurisy
###end title 14
###begin p 15
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 525 526 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 71 75 <span type="species:ncbi:10090">Mice</span>
Carrageenan-induced pleurisy was induced as previously described [32]. Mice were anesthetized with isoflurane and submitted to a skin incision at the level of the left sixth intercostals space. The underlying muscle was dissected and saline (0.2 ml) or saline containing 1% (w/v) lambda-carrageenan (0.2 ml) was injected into the pleural cavity. The skin incision was closed with a suture and the animals were allowed to recover. At 4 h and 24 h after the injection of carrageenan, the animals were killed by inhalation of CO2. The chest was carefully opened and the pleural cavity rinsed with 2 ml of saline solution containing heparin (5 U/ml) and indomethacin (10 mug/ml). The exudate and washing solution were removed by aspiration and the total volume measured. Any exudate, which was contaminated with blood, was discarded. The amount of exudate was calculated by subtracting the volume injected (2 ml) from the total volume recovered. The leukocytes in the exudate were suspended in phosphate-buffer saline (PBS, 0.01 M, pH7.4) and counted with an optical microscope in a Burker's chamber after vital Trypan Blue staining.
###end p 15
###begin title 16
Histological examination
###end title 16
###begin p 17
Lung biopsies were taken 4 h and 24 h after carrageenan injection. Tissues biopsies were fixed for 1 week in 10 % (w/v) PBS-buffered formaldehyde solution at room temperature, dehydrated using graded ethanol and embedded in Paraplast (Sherwood Medical, Mahwah, NJ, USA). Lung sections were then deparaffinized with xylene, stained with hematoxylin and eosin. All sections were studied using light microscopy (Dialux 22 Leitz).
###end p 17
###begin title 18
Measurement of cytokines
###end title 18
###begin p 19
###xml 173 175 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
TNF-alpha production was evaluated in the pleural exudate and lung tissues at 4 h and 24 h after the induction of pleurisy by carrageenan injection as previously described [33]. The assay was carried out using a colorimetric commercial ELISA kit (Calbiochem-Novabiochem Corporation, Milan, Italy) with a lower detection limit of 10 pg/ml.
###end p 19
###begin title 20
Immunohistochemical localization of TNF-alpha, BAX- BCL-2 Claudin-2, Claudin-4, Claudin-5, ZO-I and beta-catenin
###end title 20
###begin p 21
###xml 809 864 804 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Claudin-2, Claudin-4, Claudin-5, ZO-I and &#946;-catenin </italic>
###xml 1133 1177 1119 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Claudin-4, Claudin-5, ZO-I and &#946;-catenin </italic>
###xml 1854 1856 1837 1839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N </italic>
###xml 1916 1918 1899 1901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 377 381 <span type="species:ncbi:9925">goat</span>
###xml 1111 1117 <span type="species:ncbi:9986">rabbit</span>
###xml 1332 1336 <span type="species:ncbi:9925">goat</span>
###xml 1342 1348 <span type="species:ncbi:9986">rabbit</span>
At 4 and 24 h after carrageenan injection, tissues were fixed in 10% (w/v) PBS-buffered formaldehyde and 5 mum sections were prepared from paraffin embedded tissues. After deparaffinization, endogenous peroxidase was quenched with 0.3% (v/v) hydrogen peroxide in 60% (v/v) methanol for 30 min. Non-specific adsorption was minimized by incubating the section in 2% (v/v) normal goat serum in PBS for 20 min. Endogenous biotin or avidin binding sites were blocked by sequential incubation for 15 min with biotin and avidin (DBA, Milan, Italy), respectively. Sections were incubated overnight with 1) with anti-TNF-alpha antibody (Santa Cruz, 1:100 in PBS w/v,) or 3) with anti-Bax antibody (Santa Cruz, 1:50 in PBS v/v) or 4) with anti-Bcl-2 antibody (Santa Cruz 1:100 in PBS v/v). After deparaffinization, for Claudin-2, Claudin-4, Claudin-5, ZO-I and beta-catenin detection, slices were treated with protease (type XIV, Sigma) (2 mg/ml) and for 10 min at 37degreesC. Detection of BCL-2 and Bax was carried out after boiling in citrate buffer, 0.01 M for 4 min. Sections were incubated overnight with polyclonal rabbit anti-claudin-2 Claudin-4, Claudin-5, ZO-I and beta-catenin antibody (1:100 in PBS, w/v). Sections were washed with PBS and incubated with secondary antibody. Specific labeling was detected with a biotin-conjugated goat anti-rabbit IgG and avidin-biotin peroxidase complex (DBA, Milan, Italy). The counter stain was developed with DAB (brown color) and nuclear fast red (red background). To verify the binding specificity, some sections were also incubated with only the primary antibody (no secondary) or with only the secondary antibody (no primary). In these situations no positive staining was found in the sections indicating that the immunoreaction was positive in all the experiments carried out. Immunocytochemistry photographs (N = 5) were assessed by densitometry as previously described [34] by using Imaging Densitometer (AxioVision, Zeiss, Milan, Italy) and a computer program. In particular the densitometry analysis was carried out in section in which the lung was orientated in order to observe all the histological portions. In this type of section, is possible to evaluate the presence/absence or the alteration of the distribution pattern.
###end p 21
###begin title 22
Myeloperoxidase activity
###end title 22
###begin p 23
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
Myeloperoxidase (MPO) activity, an indicator of polymorphonuclear leukocyte (PMN) accumulation, was determined as previously described [35]. At the specified time following injection of carrageenan, paw and lung tissues were obtained and weighed, each piece homogenized in a solution containing 0.5% (w/v) hexadecyltrimethyl-ammonium bromide dissolved in 10 mM potassium phosphate buffer (pH 7) and centrifuged for 30 min at 20,000 x g at 4degreesC. An aliquot of the supernatant was then allowed to react with a solution of tetramethylbenzidine (1.6 mM) and 0.1 mM hydrogen peroxide. The rate of change in absorbance was measured spectrophotometrically at 650 nm. MPO activity was defined as the quantity of enzyme degrading 1 mumol of peroxide/min at 37degreesC and was expressed in units per g of wet tissue.
###end p 23
###begin title 24
TUNEL Assay
###end title 24
###begin p 25
###xml 302 303 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 304 306 303 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 668 679 <span type="species:ncbi:3704">horseradish</span>
TUNEL assay was conducted by using a TUNEL detection kit according to the manufacturer's instructions (Apotag, HRP kit DBA, Milan, Italy). Briefly, sections were incubated with 15 mug/ml proteinase K for 15 min at room temperature and then washed with PBS. Endogenous peroxidase was inactivated by 3% H2O2 for 5 min at room temperature and then washed with PBS. Sections were immersed in terminal deoxynucleotidyltransferase (TdT) buffer containing deoxynucleotidyl transferase and biotinylated dUTP in TdT buffer, incubated in a humid atmosphere at 37degreesC for 90 min, and then washed with PBS. The sections were incubated at room temperature for 30 min with anti-horseradish peroxidase-conjugated antibody, and the signals were visualized with diaminobenzidine.
###end p 25
###begin p 26
From each biopsy, at least 4 bronchiolar profiles were evaluated under a light microscope at a x20 magnification for TUNEL-positive cells. The percentage is calculated as the number of positive cells/total number of bronchial epithelial cells.
###end p 26
###begin title 27
Statistical evaluation
###end title 27
###begin p 28
###xml 134 142 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 150 152 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 552 561 550 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">post-hoc </italic>
###xml 594 595 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
All values in the figures and text are expressed as mean +/- standard error of the mean (s.e.m.) from 10 mice for each group. For the in vivo studies n represents the number of animals studied. In the experiments involving histology or immunohistochemistry, the figures shown are representative at least three experiments (histological or immunohistochemistry coloration) performed on different experimental days on the tissues section collected from all the animals in each group. The results were analyzed by one-way ANOVA followed by a Bonferroni's post-hoc test for multiple comparisons. A p-value of less than 0.05 was considered significant.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Effects of TNF-alpha gene deletion and Etanercept administration on TNFalpha production
###end title 30
###begin p 31
###xml 412 413 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 646 647 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 843 857 815 829 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown</bold>
###xml 899 901 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 942 944 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 1018 1020 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 1020 1046 988 1014 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1051 1053 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1077 1079 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2d</xref>
###xml 1079 1105 1047 1073 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1110 1112 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1419 1421 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2e</xref>
###xml 1421 1447 1377 1403 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1452 1454 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1478 1480 1434 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2f</xref>
###xml 1480 1506 1436 1462 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1511 1513 1467 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1810 1812 1762 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2g</xref>
###xml 1812 1838 1764 1790 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1843 1845 1795 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1869 1871 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2h</xref>
###xml 1871 1897 1823 1849 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1902 1904 1854 1856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1321 1325 <span type="species:ncbi:10090">mice</span>
###xml 1547 1551 <span type="species:ncbi:10090">mice</span>
To test whether TNF-alpha gene may modulate the inflammatory process leading to structural and functional alterations in pulmonary TJ function in vivo, we analyzed the levels of this pro-inflammatory cytokine in TNF-alphaR1KO and WT mice. A substantial increase of TNF-alpha production was found in pleural exudates and in the lung tissues collected from WT mice at 4 h and 24 h after carrageenan injection (Fig 1). Pleural exudates and lung tissues production of TNF-alpha were significantly reduced in carrageenan-injected TNF-alphaR1KO mice as well as in WT mice treated with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) (Fig. 1). Therefore, we also evaluate the TNF-alpha expression in the lung tissues by immunohistochemical detection. No positive staining for TNF-alpha was observed in the lung tissues collected at 4 h (data not shown) and at 24 hours from sham WT mice (Fig. 2a) and from sham TNF-alphaR1KO mice (Fig. 2b). On the contrary, tissue sections obtained from WT animals at 4 h (Fig. 2csee densitometry analysis Fig. 3a) and at 24 hours (Fig. 2dsee densitometry analysis Fig. 3b) after carrageenan injection demonstrate positive staining for TNF-alpha mainly localized in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall. In carrageenan-injected TNF-alphaR1KO mice, no positive staining for TNF-alpha were observed in the lung tissues collected at 4 h (Fig. 2esee densitometry analysis Fig. 3a) and at 24 hours (Fig. 2fsee densitometry analysis Fig. 3b). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly reduced the positive staining for TNF-alpha in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall in the lung tissues collected at 4 h (Fig. 2gsee densitometry analysis Fig. 3a) and at 24 hours (Fig. 2hsee densitometry analysis Fig. 3a).
###end p 31
###begin p 32
###xml 145 146 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 166 167 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 340 341 324 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 603 604 571 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1002 1004 960 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1011 1013 969 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1028 1030 980 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1037 1039 989 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
Effects of TNF-alpha gene deletion and Etanercept administration on TNFalpha levels. TNF-alpha production was evaluated in the pleural exudates (a) and lung tissues (b) collected at 4 h and 24 h after carrageenan administration using a colorimetric commercial ELISA kit. A significant production TNF-alpha was observed in pleural exudates (a) collected from WT mice. The absence of TNF-alpha receptor 1 gene in mice (TNF-alphaR1KO) as well as the treatment of WT mice with Etanercept significantly reduced the pleural exudate production of TNF-alpha. Similarly, a significant increase of the TNF-alpha (b) was observed in the lung tissues from carrageenan-injected WT mice at 4 and 24 hours after carrageenan. In the lung tissues from carrageenan-injected TNF-alphaR1KO mice as well as of WT mice which have received with Etanercept the TNF-alpha levels were significantly reduced in comparison to those of WT animals measured in the same conditions. Data are means +/- SEM of 10 mice for each group. *P < 0.01 vs. SHAM; degreesP < 0.01 vs. carrageenan- WT group.
###end p 32
###begin p 33
###xml 168 169 160 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 205 206 193 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 275 276 263 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 295 296 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 598 599 574 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 618 619 594 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 911 912 883 884 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 931 932 903 904 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of TNF-alpha in the lung. No positive staining for TNF-alpha was observed in the lung tissues collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b). On the contrary, tissue sections obtained from WT animals at 4 h (c) and at 24 hours (d) after carrageenan injection demonstrate positive staining for TNF-alpha mainly localized in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall. In carrageenan-injected TNF-alphaR1KO mice, no positive staining for TNF-alpha were observed in the lung tissues collected at 4 h (e) and at 24 hours (f). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly reduced the positive staining for TNF-alpha in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall in the lung tissues collected at 4 h (g) and at 24 hours (h). Figure is representative of at least 3 experiments performed on different experimental days.
###end p 33
###begin p 34
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Typical Densitometry evaluation</bold>
###xml 447 449 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 456 458 449 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 473 474 460 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 480 482 467 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Typical Densitometry evaluation. Densitometry analysis of immunocytochemistry photographs (n = 5 photos from each sample collected from all mice in each experimental group) for TNF-alpha, Bax, Bcl-2 Claudin-2, Claudin-4, Claudin-5, ZO-I and beta-catenin from lung tissues was assessed. The assay was carried out by using Imaging Densitometer (AxioVision, Zeiss, Milan, Italy) on a personal computer. Data are expressed as % of total tissue area. *P < 0.01 vs. SHAM; degreesP<0.01 vs. carrageenan- WT group ND: not detectable.
###end p 34
###begin title 35
Effects of TNF-alpha gene deletion and Etanercept administration on apoptosis in acute lung inflammation
###end title 35
###begin p 36
###xml 274 276 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 276 309 272 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see (TUNEL)-positive cells count </bold>
###xml 313 315 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h</xref>
###xml 331 335 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4bb1</xref>
###xml 335 368 331 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see (TUNEL)-positive cells count </bold>
###xml 372 374 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h</xref>
###xml 391 395 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4cc1</xref>
###xml 395 428 391 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see (TUNEL)-positive cells count </bold>
###xml 432 434 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h</xref>
###xml 779 781 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4d</xref>
###xml 781 814 769 802 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see (TUNEL)-positive cells count </bold>
###xml 818 820 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h</xref>
###xml 844 846 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4e</xref>
###xml 846 879 834 867 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see (TUNEL)-positive cells count </bold>
###xml 883 885 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h</xref>
###xml 1126 1128 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4f</xref>
###xml 1128 1161 1116 1149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see (TUNEL)-positive cells count </bold>
###xml 1165 1167 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h</xref>
###xml 1191 1193 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4g</xref>
###xml 1193 1226 1181 1214 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see (TUNEL)-positive cells count </bold>
###xml 1230 1232 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4h</xref>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
To test whether functional TNF-alpha gene plays a role on apoptosis in acute lung inflammation, we measured TUNEL-like staining in the lung tissues at 4 h and 24 h after carrageenan administration. Almost no apoptotic cells were detected in the lung from sham-treated (Fig. 4asee (TUNEL)-positive cells count Fig 4h). At 4 h (Fig. 4bb1see (TUNEL)-positive cells count Fig 4h) and 24 h (Fig. 4cc1see (TUNEL)-positive cells count Fig 4h) after the induction of lung inflammation by carrageenan administration, lung tissues demonstrated a marked appearance of dark brown apoptotic cells and intercellular apoptotic fragments. The presence of apoptotic cells or fragments were significantly reduced in the absence of a functional TNF-alpha R1 gene in TNF-alphaR1KO mice at 4 h (Fig. 4dsee (TUNEL)-positive cells count Fig 4h) and at 24 hours (Fig. 4esee (TUNEL)-positive cells count Fig 4h) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered sc 2 h prior carrageenan) visibly and significantly reduced the number of apoptotic cells or fragments in the lung tissues collected at 4 h (Fig. 4fsee (TUNEL)-positive cells count Fig 4h) and at 24 hours (Fig. 4gsee (TUNEL)-positive cells count Fig 4h).
###end p 36
###begin p 37
###xml 150 151 146 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 192 195 188 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">bb1</bold>
###xml 207 210 203 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink">cc1</bold>
###xml 550 551 538 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 570 571 558 559 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 807 808 795 796 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 827 828 815 816 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 842 843 830 831 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 968 970 954 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 977 979 963 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 994 996 974 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1003 1005 983 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
Effects of TNF-alpha gene deletion and Etanercept administration on apoptosis. Almost no apoptotic cells were detected in the lung from sham-treated (a) tissues collected at 24 hours. At 4 h (bb1) and 24 h (cc1) after the induction of lung inflammation by carrageenan administration, lung tissues demonstrated a marked appearance of dark brown apoptotic cells and intercellular apoptotic fragments. The presence of apoptotic cells or fragments were significantly reduced in the absence of a functional TNF-alpha R1 gene in TNF-alphaR1KO mice at 4 h (d) and at 24 hours (e) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered sc 2 h prior carrageenan) visibly and significantly reduced the number of apoptotic cells or fragments in the lung tissues collected at 4 h (f) and at 24 hours (g). The graph (h) shows the mean +/- SE of percentage TUNEL positive epithelial cells in biopsies from mice in all the experimental groups. *P < 0.01 vs. SHAM; degreesP < 0.01 vs. carrageenan- WT group ND: not detectable. Figure is representative of at least 3 experiments performed on different experimental days.
###end p 37
###begin p 38
Moreover, samples of lung tissue were taken at 4 and 24 h after carrageenan administration in order to determine the immunohistological staining for Bax and Bcl-2.
###end p 38
###begin p 39
###xml 80 94 80 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown</bold>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 138 164 138 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 212 214 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 214 240 210 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 245 247 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 316 357 312 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown see densitometry analysis </bold>
###xml 362 364 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 388 390 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 390 416 386 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 421 423 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 617 659 609 651 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown, see densitometry analysis </bold>
###xml 664 666 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 690 692 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5d</xref>
###xml 692 718 684 710 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 723 725 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 904 946 896 938 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown, see densitometry analysis </bold>
###xml 951 953 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 977 979 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e</xref>
###xml 979 1005 971 997 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1010 1012 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
No positive staining for Bax was observed in the lung tissues collected at 4 h (data not shown) and at 24 hours from sham WT mice (Fig. 5asee densitometry analysis Fig. 3a) and from sham TNF-alphaR1KO mice (Fig. 5bsee densitometry analysis Fig. 3b). On the contrary, tissue sections obtained from WT animals at 4 h (data not shown see densitometry analysis Fig. 3a) and at 24 hours (Fig. 5csee densitometry analysis Fig. 3b) after carrageenan injection demonstrate positive staining for Bax. In carrageenan-injected TNF-alphaR1KO mice, no positive staining for Bax were observed in the lung tissues collected at 4 h (data not shown, see densitometry analysis Fig. 3a) and at 24 hours (Fig. 5dsee densitometry analysis Fig. 3b). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered sc 2 h prior carrageenan) reduced the degree of positive staining for Bax in the lung tissues at 4 h (data not shown, see densitometry analysis Fig. 3a) and at 24 hours (Fig. 5esee densitometry analysis Fig. 3b).
###end p 39
###begin p 40
###xml 218 219 218 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 255 256 251 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 330 331 326 327 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 632 633 620 621 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 924 925 912 913 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of Bax in the lung. Lung biopsies were taken 24 h after injection of carrageenan. No positive staining for Bax was observed in the lung tissues collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b). On the contrary, tissue sections obtained from WT animals at 24 hours (c) after carrageenan injection demonstrate positive staining for TNF-alpha mainly localized in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall. In carrageenan-injected TNF-alphaR1KO mice, no positive staining for Bax were observed in the lung tissues collected at 24 hours (d). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly reduced the positive staining for Bax in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall in the lung tissues collected at 24 hours (e). Figure is representative of at least 3 experiments performed on different experimental days.
###end p 40
###begin p 41
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 60 86 60 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 134 136 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 136 162 132 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 167 169 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 302 344 298 340 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown, see densitometry analysis </bold>
###xml 349 351 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 375 377 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c</xref>
###xml 377 403 373 399 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 408 410 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 549 591 541 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown, see densitometry analysis </bold>
###xml 596 598 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 622 624 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6d</xref>
###xml 624 650 616 642 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 655 657 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 839 881 831 873 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown, see densitometry analysis </bold>
###xml 886 888 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 912 914 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6e</xref>
###xml 916 942 908 934 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 947 949 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
In addition, lung tissue sections from sham WT mice (Fig. 6asee densitometry analysis Fig. 3b) and from sham TNF-alphaR1KO mice (Fig. 6bsee densitometry analysis Fig. 3b) demonstrated Bcl-2 positive staining while in the lung from carrageenan-treated WT mice the staining significantly reduced at 4 h (data not shown, see densitometry analysis Fig. 3a) and at 24 hours (Fig. 6csee densitometry analysis Fig. 3a). In carrageenan-injected TNF-alphaR1KO mice, a regular presence of Bcl-2 distribution was observed in the lung tissues collected at 4 h (data not shown, see densitometry analysis Fig. 3a) and at 24 hours (Fig. 6dsee densitometry analysis Fig. 3b). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered sc 2 h prior carrageenan) attenuated the loss of positive staining for Bcl-2 in the lung tissues at 4 h (data not shown, see densitometry analysis Fig. 3a) and at 24 hours (Fig. 6e, see densitometry analysis Fig. 3a).
###end p 41
###begin p 42
###xml 179 180 179 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 216 217 212 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 359 360 355 356 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 504 505 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 692 693 684 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of Bcl-2 in the lung. Lung biopsies were taken 24 h after injection of carrageenan. Lung tissue sections collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b) demonstrated Bcl-2 positive staining while in the lung from carrageenan-treated WT mice the staining significantly reduced and at 24 hours (c). In carrageenan-injected TNF-alphaR1KO mice, a regular presence of Bcl-2 distribution was observed in the lung tissues collected at 24 hours (d). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered sc 2 h prior carrageenan) attenuated the loss of positive staining for Bcl-2 in the lung tissues at 24 hours (e). Figure is representative of at least 3 experiments performed on different experimental days.
###end p 42
###begin title 43
Lower levels of leukocyte extravasation and of tissue permeability correlate with a different modulation of TNF-alpha gene deletion and Etanercept administration on epithelian/endothelial function during pleurisy
###end title 43
###begin p 44
###xml 548 550 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 592 594 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 950 952 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
It is known that pro-inflammatory mediators modulate epithelial and endothelial function, which, in turn, favors the extravasation and recruitment of leukocytes further amplifying the inflammatory response. Therefore, we investigate the role of functional TNF-alpha gene on the polymorphonuclear cells (PMNs) in the pleural cavity. When compared to the number of cells collected from the pleural space from sham WT mice and sham TNF-alphaR1KO mice, injection of carrageenan induced a significant time dependent increase in the number of PMNs (Fig. 7a). The number of inflammatory cells (Fig. 7a) in the pleural cavity at 4 and 24 hours after carrageenan administration was significantly reduced in the absence of a functional TNF-alphaR1 gene in TNF-alphaR1KO mice. Similarly, treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) significantly reduced the inflammatory cell infiltration in the pleaural cavity (Fig. 7a).
###end p 44
###begin p 45
###xml 147 148 143 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 200 201 196 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 256 257 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 546 547 534 535 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1202 1204 1184 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1211 1213 1193 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1228 1230 1204 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1237 1239 1213 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 1180 1184 <span type="species:ncbi:10090">mice</span>
Effects of TNF-alpha gene deletion and Etanercept administration on carrageenan-induced accumulation of polymorphonuclear cells in pleural cavity (a) and neutrophils infiltration in the lung tissues (b). A significant polymorphonuclear cells infiltration (a) was observed in pleural cavity of WT mice at 4 h and 24 h after carrageenan administration. The absence of TNF-alpha receptor 1 gene in mice (TNF-alphaR1KO) as well as the treatment of WT mice with Etanercept significantly reduced the number of inflammatory cells in the pleural cavity (a) at 4 and 24 hours after carrageenan injection. In addition, at 4 and 24 hrs, the neutrophils infiltration by measurement of the activity of myeloperoxidase. Myeloperoxidase activity was significantly elevated at 4 h and 24 h after carrageenan administration in WT mice. In TNF-alphaR1KO mice lung myeloperoxidase activity was significantly reduced at 4 h and at 24 hours. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) significantly reduced the neutrophils infiltration in the lung tissues at 4 h and at 24 hours after carrageenan administration. Data are means +/- SEM of 10 mice for each group. *P < 0.01 vs. SHAM; degreesP < 0.01 vs. carrageenan- WT group.
###end p 45
###begin p 46
###xml 417 419 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 582 584 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 817 819 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
The important presence of inflammatory cells in the pleural cavity appeared to be correlated with the influx of leukocytes into the lung tissue. Therefore, we investigate the role of functional TNF-alpha gene on the neutrophils infiltration by measurement of the activity of myeloperoxidase. Myeloperoxidase activity was significantly elevated (p < 0.001) at 4 h and 24 h after carrageenan injection in WT mice (Fig. 7b). In lung from TNF-alphaR1KO mice myeloperoxidase activity was significantly reduced at 4 h and at 24 hours (p < 0.01) in comparison to those of WT animals (Fig. 7b). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) significantly reduced the neutrophils infiltration in the lung tissues at 4 h and at 24 hours after carrageenan-injection (Fig. 7b).
###end p 46
###begin p 47
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 379 420 379 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown see densitometry analysis </bold>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a</xref>
###xml 471 497 471 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 545 547 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 547 573 543 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 578 580 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 892 894 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8c</xref>
###xml 894 920 890 916 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 925 927 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 951 953 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8d</xref>
###xml 953 979 949 975 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 984 986 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1185 1187 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8e</xref>
###xml 1187 1213 1179 1205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1218 1220 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1244 1246 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8f</xref>
###xml 1246 1272 1238 1264 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1277 1279 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1626 1628 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8g</xref>
###xml 1628 1654 1616 1642 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1659 1661 1647 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1685 1687 1673 1675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8h</xref>
###xml 1687 1713 1675 1701 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1718 1720 1706 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
###xml 1450 1454 <span type="species:ncbi:10090">mice</span>
During the inflammatory process, tissue permeability is modified in part by changes in tight junctions [2,36]. Since ZO-1 is implicated in tight junction regulation and was used as a marker of cellular barrier integrity [37], we performed immunoistochemistry experiments to evaluate ZO-1 distribution in lung sections. Results indicate that in the lung tissues collected at 4 h (data not shown see densitometry analysis Fig. 3a) and at 24 hours from sham WT mice (Fig. 8asee densitometry analysis Fig. 3b) and from sham TNF-alphaR1KO mice (Fig. 8bsee densitometry analysis Fig. 3b), ZO-1 was uniformly and continuously distributed along the alveolar epithelium and the vascular endothelium. In contrast, a significant disruption of immuno-signal for ZO-1 was observed along the alveolar epithelium and the vascular endothelium in the lung sections of carrageenan-treated WT mice at 4 h (Fig. 8csee densitometry analysis Fig. 3a) and at 24 hours (Fig. 8dsee densitometry analysis Fig. 3b) after carrageenan. In lungs of carrageenan-treated TNF-alphaR1KO mice, a more regular distribution pattern of ZO-1 along the alveolar epithelium and the vascular endothelium was found at 4 h (Fig. 8esee densitometry analysis Fig. 3a) and at 24 hours (Fig. 8fsee densitometry analysis Fig. 3b), thus indicating that in carrageenan-treated TNF-alphaR1KO mice carrageenan treatment provokes a lower degree of disorganization of ZO-1. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly reduced the disorganization of ZO-1 in the lung tissues collected at 4 h (Fig. 8gsee densitometry analysis Fig. 3a) and at 24 hours (Fig. 8hsee densitometry analysis Fig. 3b).
###end p 47
###begin p 48
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 156 157 152 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 464 465 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 484 485 480 481 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 679 680 671 672 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 699 700 691 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1042 1043 1030 1031 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1062 1063 1050 1051 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of ZO-1 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b), ZO-1 was uniformly and continuously distributed along the alveolar epithelium and the vascular endothelium. In contrast, a significant disruption of immuno-signal for ZO-1 was observed along the alveolar epithelium and the vascular endothelium in the lung sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. In lungs of carrageenan-treated TNF-alphaR1KO mice, a more regular distribution pattern of ZO-1 along the alveolar epithelium and the vascular endothelium was found at 4 h (e) and at 24 hours (f), thus indicating that in carrageenan-treated TNF-alphaR1KO mice carrageenan treatment provokes a lower degree of disorganization of ZO-1. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly reduced the disorganization of ZO-1 in the lung tissues collected at 4 h (g) and at 24 hours (h). Figure is representative of at least 3 experiments performed on different experimental days.
###end p 48
###begin p 49
###xml 73 114 73 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown see densitometry analysis </bold>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 207 211 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9a,b</xref>
###xml 211 250 207 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively see densitometry analysis </bold>
###xml 255 257 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 276 281 272 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10a,b</xref>
###xml 281 320 277 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively see densitometry analysis </bold>
###xml 325 327 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 346 351 342 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11a,b</xref>
###xml 351 390 347 386 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively see densitometry analysis </bold>
###xml 395 397 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 422 427 415 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12a,b</xref>
###xml 427 467 420 460 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively, see densitometry analysis </bold>
###xml 472 474 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 685 688 678 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9cd</xref>
###xml 688 700 681 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 719 723 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10bc</xref>
###xml 723 735 716 728 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 754 758 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11cd</xref>
###xml 758 770 751 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 795 799 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12cd</xref>
###xml 799 813 789 803 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively) </bold>
###xml 894 920 884 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 925 927 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 939 965 929 955 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 970 972 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1109 1112 1095 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9ef</xref>
###xml 1112 1125 1098 1111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively)</bold>
###xml 1143 1147 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10de</xref>
###xml 1147 1160 1133 1146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively)</bold>
###xml 1178 1182 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11ef</xref>
###xml 1182 1196 1168 1182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively) </bold>
###xml 1219 1223 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12ef</xref>
###xml 1223 1235 1206 1218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 1245 1271 1228 1254 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1276 1278 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1297 1323 1280 1306 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1328 1330 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1519 1522 1502 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9gh</xref>
###xml 1522 1534 1505 1517 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 1553 1557 1536 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10ef</xref>
###xml 1557 1569 1540 1552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 1588 1592 1571 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11gh</xref>
###xml 1592 1604 1575 1587 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 1629 1633 1609 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12gh</xref>
###xml 1633 1645 1613 1625 <bold xmlns:xlink="http://www.w3.org/1999/xlink">respectively</bold>
###xml 1655 1681 1635 1661 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1686 1688 1666 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1707 1733 1687 1713 <bold xmlns:xlink="http://www.w3.org/1999/xlink">see densitometry analysis </bold>
###xml 1738 1740 1718 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 881 885 <span type="species:ncbi:10090">mice</span>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
###xml 1364 1368 <span type="species:ncbi:10090">mice</span>
In addition, results indicate that in the lung tissues collected at 4 h (data not shown see densitometry analysis Fig. 3a) and at 24 hours from sham WT mice and from sham TNF-alphaR1KO mice, Claudin-2 (Fig. 9a,brespectively see densitometry analysis Fig. 3b), Claudin-4 (Fig. 10a,brespectively see densitometry analysis Fig. 3b), Claudin-5 (Fig. 11a,brespectively see densitometry analysis Fig. 3b) and beta-catenin (Fig. 12a,brespectively, see densitometry analysis Fig. 3b) were uniformly and continuously distributed along the alveolar epithelium and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for Claudin-2 (Fig. 9cdrespectively), Claudin-4 (Fig. 10bcrespectively), Claudin-5 (Fig. 11cdrespectively) and beta-catenin (Fig. 12cdrespectively) was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (see densitometry analysis Fig. 3a) and 24 h (see densitometry analysis Fig. 3b) after carrageenan. In lungs of carrageenan-treated TNF-alphaR1KO mice was found less irregular distribution pattern of Claudin-2 (Fig. 9efrespectively), Claudin-4 (Fig. 10derespectively), Claudin-5 (Fig. 11efrespectively) and beta-catenin (Fig. 12efrespectively) at 4 h (see densitometry analysis Fig. 3a) and at 24 hours (see densitometry analysis Fig. 3a). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) were able to prevent carrageenan-induced distribution alteration of Claudin-2 (Fig. 9ghrespectively), Claudin-4 (Fig. 10efrespectively), Claudin-5 (Fig. 11ghrespectively) and beta-catenin (Fig. 12ghrespectively) at 4 h (see densitometry analysis Fig. 3a) and at 24 hours (see densitometry analysis Fig. 3a).
###end p 49
###begin p 50
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 161 162 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 459 460 455 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 479 480 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 619 620 611 612 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 639 640 631 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 849 850 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 869 870 861 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of Claudin-2 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b), Claudin-2 were uniformly and continuously distributed along the alveolar epithelium and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for Claudin-2 was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. In lungs of carrageenan-treated TNF-alphaR1KO mice was found less irregular distribution pattern of Claudin-2 at 4 h (e) and at 24 hours (f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) were able to prevent carrageenan-induced distribution alteration of Claudin-2 at 4 h (g) and at 24 hours (h) after carrageenan. Figure is representative of at least 3 experiments performed on different experimental days.
###end p 50
###begin p 51
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 161 162 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 459 460 455 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 479 480 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 619 620 611 612 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 639 640 631 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 849 850 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 869 870 861 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of Claudin-4 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b), Claudin-4 were uniformly and continuously distributed along the alveolar epithelium and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for Claudin-4 was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. In lungs of carrageenan-treated TNF-alphaR1KO mice was found less irregular distribution pattern of Claudin-4 at 4 h (e) and at 24 hours (f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) were able to prevent carrageenan-induced distribution alteration of Claudin-4 at 4 h (g) and at 24 hours (h) after carrageenan. Figure is representative of at least 3 experiments performed on different experimental days.
###end p 51
###begin p 52
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 161 162 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 459 460 455 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 479 480 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 619 620 611 612 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 639 640 631 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 849 850 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 869 870 861 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of Claudin-5 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b), Claudin-5 were uniformly and continuously distributed along the alveolar epithelium and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for Claudin-5 was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. In lungs of carrageenan-treated TNF-alphaR1KO mice was found less irregular distribution pattern of Claudin-5 at 4 h (e) and at 24 hours (f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) were able to prevent carrageenan-induced distribution alteration of Claudin-5 at 4 h (g) and at 24 hours (h) after carrageenan. Figure is representative of at least 3 experiments performed on different experimental days.
###end p 52
###begin p 53
###xml 127 128 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 164 165 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 468 469 455 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 488 489 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 631 632 611 612 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 651 652 631 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 864 865 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 884 885 861 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
Immunohistochemical localization of beta-catenin in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) and from sham TNF-alphaR1KO mice (b), beta-catenin were uniformly and continuously distributed along the alveolar epithelium and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for beta-catenin was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. In lungs of carrageenan-treated TNF-alphaR1KO mice was found less irregular distribution pattern of beta-catenin at 4 h (e) and at 24 hours (f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) were able to prevent carrageenan-induced distribution alteration of beta-catenin at 4 h (g) and at 24 hours (h) after carrageenan. Figure is representative of at least 3 experiments performed on different experimental days.
###end p 53
###begin p 54
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12</xref>
###xml 491 493 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12</xref>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
A massive increase in the lung permeability was observed at 4 and 24 h after carrageenan administration, as evidenced by a marked increase in the pleural exudates formation in WT mice (Fig. 12). Significant reduction of pleural exudates formation was observed at 4 and 24 h after carrageenan administration in carrageenan-treated TNF-alphaR1KO mice as well as increase in the carrageenan-treated WT mice which have received Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) (Fig. 12).
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1282 1284 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1409 1411 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1587 1589 1587 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1590 1592 1590 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1819 1821 1819 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1926 1928 1926 1928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 2084 2086 2084 2086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
The gas exchanging air-blood barriers in the lung are composed of the microvascular pulmonary endothelium and the epithelial lining of the alveoli, which form three separate compartments: blood, interstitium, and the alveolar space. Acute lung injury and its most severe form, the acute respiratory distress syndrome (ARDS), are conditions characterized by a diffuse, intense inflammatory process, by damage to both endothelial and epithelial cell barriers, resulting in marked extravasation of vascular fluid [38]. The filling of alveolar spaces by proteinaceous edema fluid and inflammatory cells leads to severe hypoxemia and respiratory failure [38]. The normal functioning of the lung depends on the establishment and maintenance of a milieu in the alveolar space that is distinct from the composition of the subepithelial compartment. This process depends on the formation and proper functioning of specialized structures, called tight junctions (TJ), between adjacent cells making up the epithelial sheet. The TJ is a complex of several integral membrane proteins and peripheral membrane proteins that interact strongly with the cytoskeleton [39]. Integral membrane proteins involved in TJ formation include occludin and members of a large class of proteins called claudins [39]. These proteins contain four transmembrane domains and are thought to be the points of cell-to-cell contact within the TJ [40]. Cosedimentation assays of TJ proteins suggest that there is a strong interaction between occludin and another protein associated with TJ formation, zonula occludens (ZO)-1 [41,42]. ZO-1 has been shown to interact with the cytoplasmic tails of occludin and the claudins. In addition, ZO-1 interacts with two additional members of the membrane-associated guanylate kinase family of proteins, ZO-2 and ZO-3 [43]. The TJ serves as a fence that differentiates the plasma membrane into apical and basolateral domains [44]. TJs also serve as a regulated semipermeable barrier that limits the passive diffusion of solutes across the paracellular pathway between adjacent cells [45]. These properties of TJs, in combination with transcellular vectorial transport processes, generate distinct internal environments in the opposing compartments.
###end p 56
###begin p 57
###xml 218 220 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 394 396 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
Recently, we have demonstrated, using an experimental model of colitis, that the structure and function of TJs in the intestinal epithelial is dependent of the production of proinflammatory cytokines (e.g. TNF-alpha) [34]. In particular in one study, we have showed that the structure and function of TJs in the ileum were altered in mice at 4 days after the induction of experimental colitis [34]. These changes were ameliorated when mice were treated with Thalidomide. In the study reported here, we obtained similar results and showed that the structure and function of TJs in the lung were altered in mice injected 4 and 24 h earlier with carrageenan. Moreover, these changes were ameliorated by treatment with Etanercept, a TNF-alpha soluble receptor construct, as well as in mice with a targeted deletion of the TNF-alphaR1 gene. As a result of these efforts, we point out that acute lung inflammation induced alterations in the function of lungs, is due, at least in part, to massive changes in the expression and localization of key TJ proteins. Furthermore, we propose that excessive TNF-alpha production is an important component of this process.
###end p 57
###begin p 58
What is then the mechanism by which inhibition of TNF-alpha induced the structure and function of TJs alteration in acute inflammation caused by carrageenan?
###end p 58
###begin p 59
###xml 115 117 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 118 120 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
There is good evidence that TNF-alpha help to propagate the extension of a local or systemic inflammatory process [46,47]. We confirm here that carrageenan injection a substantial increase of TNF-alpha in the exudates and lung tissues which likely contribute in different capacities to the evolution of acute inflammation. As expected, the TNF-alpha levels were abolished in TNF-alphaR1KO mice and significantly reduced in the TNF-alpha R1WT mice treated with Etanercept.
###end p 59
###begin p 60
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 532 534 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 535 537 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 773 775 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1403 1405 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
Moreover various study have clearly point out that the immune system plays an important role in modulating epithelial permeability in different organs such us gut and lung [48,49]. The regulation of epithelial barrier function by cytokines has been studied most extensively in the gut using different epithelial cell line. For examples some studies have demonstrated that two cytokines, interferon-gamma (IFNgamma) and tumor necrosis factor-alpha (TNFalpha), decreased barrier function of cultured intestinal epithelial monolayers [50,51]. Moreover, incubation of intestinal epithelial cell monolayers with both IFNgamma and TNFalpha leads to reorganization of many tight junction proteins, including ZO-1, junction adhesion molecule 1, occludin, claudin-1, and claudin-4 [27]. The effects of pro-inflammatory cytokines on lung epithelial barrier function were studied using lung epithelial cells. In a recent study Ahdieh and colleagues have clearly demonstrated Th1 and Th2 cytokines have distinct activities in lung epithelial cells that are consistent with the role of these cytokines in lung inflammation (e.g. asthma) In particular, IL-4 and IL-13 disrupt epithelial barrier function and wound healing, both of which would be expected to exacerbate inflammation. In contrast, IFN-gamma enhances epithelial barrier function and wound healing, which would contribute to a reduction in inflammation [49].
###end p 60
###begin p 61
###xml 891 893 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1082 1084 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1365 1367 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 2163 2165 2132 2134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 2166 2168 2135 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
In the present study, we also demonstrate that carrageenan administration to mice induced an alteration of immunohistochemical localization signal for ZO-1, Claudin-2, Claudin-4, Claudin-5 and beta-catenin at 4 h and 24 h after carrageenan. The genetic or pharmacological inhibition of TNF-alpha abolished the alteration of tight junction permeability. Thus, a key step in the pathogenesis of acute lung injury may be myosin light chain kinase activation by TNFalpha, leading to epithelial barrier dysfunction. There is extensive literature examining the consequences of specific proinflammatory cytokines, particularly tumor necrosis factor (TNF)-alpha, on the induction of apoptosis. An important biologic effect of TNF-alpha is the induction of apoptosis through its interaction with its receptor, TNFR. However, the same TNF-TNFR ligand-receptor interaction can also activate NF-kappaB [52]. Activation of the Fas ligand is another major signaling pathway that leads to apoptosis. In bronchial epithelial cells, ligation of Fas stimulates both apoptosis and expression of IL-8 [53]. Thus, the activation of proinflammatory signaling pathways can elicit apoptotic responses as well as the expression of cytokines. The response of the normal airway epithelial cell to inflammatory stimuli may consist of activation of both apoptotic and proinflammatory cascades [52]. However, in diseases such as acute lung injury, in which there appears to be an excessive inflammatory response, the balance between the activation and suppression of these potentially opposing pathways may be abnormal. In the present study, using the tunnel coloration we have clearly confirmed that TNF-alpha plays an important role in the induction of apoptosis during acute lung injury and that the treatment with etanercept and genetic inhibition of TNF-alphaR1 attenuates the degree of apoptosis. Moreover, it is well known that Bax, a pro-apoptotic gene, plays an important role in developmental cell death (34). Similarly, it has been shown that the overexpression of Bcl-2, a known antiapoptotic factor, significantly reduced the bronchial as well as intestinal epithelial apoptosis [54,55]. Base on these evidences, we have identified proapoptotic transcriptional changes, including upregulation of proapoptotic Bax and down regulation of antiapoptotic Bcl-2 by immunohystochemical staining. We report in the present study for the first time that the treatment with etanercept and genetic inhibition of TNF-alpha R1prevents the lost of the antiapoptotic way and reduced the proapoptotic pathway activation with a mechanism still to discover.
###end p 61
###begin p 62
###xml 359 367 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
Further studies are needed to address this point. Thus, we propose the following cycle: Inflammation -> TNF-alpha-> endothelial/epithelial TJ alteration -> PMN infiltration -> more pro-inflammatory mediator release -> organ damage. The confirmation of this proposed feedback cycle, however, requires further investigation. In conclusion, we have demonstrated in vivo that the pharmacological inhibition of TNF-alpha by Etanercept attenuates the development of TJ alteration in acute inflammation in mice.
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
This study was supported by grant from Caminiti SRL foundation. The authors would like to thank Giovanni Pergolizzi and Carmelo La Spada for their excellent technical assistance during this study, Mrs Caterina Cutrona for secretarial assistance and Miss Valentina Malvagni for editorial assistance with the manuscript.
###end p 64
###begin article-title 65
Alveolar epithelial transport. Basic science to clinical medicine
###end article-title 65
###begin article-title 66
Structure, function, and regulation of cellular tight junctions
###end article-title 66
###begin article-title 67
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Heterogeneity of tight junction morphology in extrapulmonary and intrapulmonary airways of the rat
###end article-title 67
###begin article-title 68
Plugging the leaks
###end article-title 68
###begin article-title 69
Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin
###end article-title 69
###begin article-title 70
###xml 0 22 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A
###end article-title 70
###begin article-title 71
###xml 15 18 <span type="species:ncbi:10116">rat</span>
###xml 19 39 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Interaction of rat Pneumocystis carinii and rat alveolar epithelial cells in vitro
###end article-title 71
###begin article-title 72
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Complex phenotype of mice lacking occludin, a component of tight junction strands
###end article-title 72
###begin article-title 73
Repair mechanisms in asthma
###end article-title 73
###begin article-title 74
###xml 36 58 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells
###end article-title 74
###begin article-title 75
###xml 8 30 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8
###end article-title 75
###begin article-title 76
Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB
###end article-title 76
###begin article-title 77
The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum
###end article-title 77
###begin article-title 78
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
###end article-title 78
###begin article-title 79
TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1
###end article-title 79
###begin article-title 80
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
###end article-title 80
###begin article-title 81
TNF alpha and the TNF receptor superfamily: structure-function relationship(s)
###end article-title 81
###begin article-title 82
Critical advances in septicemia and septic shock
###end article-title 82
###begin article-title 83
Interaction between cytokines and oxidative stress in acute pancreatitis
###end article-title 83
###begin article-title 84
Animal models of endotoxic shock
###end article-title 84
###begin article-title 85
TNF receptor superfamily-induced cell death: redox-dependent execution
###end article-title 85
###begin article-title 86
Tumor necrosis factor: a plurifunctional mediator of acute inflammation
###end article-title 86
###begin article-title 87
The TNF and TNF receptor superfamilies: integrating mammalian biology
###end article-title 87
###begin article-title 88
The potential biological and clinical significance of the soluble tumor necrosis factor receptors
###end article-title 88
###begin article-title 89
Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments
###end article-title 89
###begin article-title 90
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice
###end article-title 90
###begin article-title 91
Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms
###end article-title 91
###begin article-title 92
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes
###end article-title 92
###begin article-title 93
TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation
###end article-title 93
###begin article-title 94
Regulation of airway tight junctions by proinflammatory cytokines
###end article-title 94
###begin article-title 95
Activation of NF-kappaB is necessary for the restoration of the barrier function of an epithelium undergoing TNF-alpha-induced apoptosis
###end article-title 95
###begin article-title 96
Peroxynitrite-mediated DNA strand breakage activates poly (ADP-ribose) synthetase and causes cellular energy depletion in carrageenan-induced pleurisy
###end article-title 96
###begin article-title 97
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy
###end article-title 97
###begin article-title 98
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis
###end article-title 98
###begin article-title 99
###xml 86 89 <span type="species:ncbi:10116">rat</span>
The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat
###end article-title 99
###begin article-title 100
Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level
###end article-title 100
###begin article-title 101
Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins
###end article-title 101
###begin article-title 102
###xml 27 32 <span type="species:ncbi:9606">human</span>
Differential regulation of human lung epithelial and endothelial barrier function by thrombin
###end article-title 102
###begin article-title 103
Tight junction proteins
###end article-title 103
###begin article-title 104
Transmembrane proteins of tight junctions
###end article-title 104
###begin article-title 105
The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton
###end article-title 105
###begin article-title 106
Molecular architecture of tight junctions
###end article-title 106
###begin article-title 107
MAGUK proteins: structure and role in the tight junction
###end article-title 107
###begin article-title 108
New perspectives on mechanisms involved in generating epithelial cell polarity
###end article-title 108
###begin article-title 109
Tight junctions and the molecular basis for regulation of paracellular permeability
###end article-title 109
###begin article-title 110
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
The modulatory role played by TNF-alpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy
###end article-title 110
###begin article-title 111
###xml 68 72 <span type="species:ncbi:10116">rats</span>
Generation of inflammatory cytokines in zymosan-induced pleurisy in rats: TNF induces IL-6 and cytokine-induced neutrophil chemoattractant (CINC) in vivo
###end article-title 111
###begin article-title 112
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo
###end article-title 112
###begin article-title 113
A porous defense: the leaky epithelial barrier in intestinal disease
###end article-title 113
###begin article-title 114
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease
###end article-title 114
###begin article-title 115
Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha
###end article-title 115
###begin article-title 116
Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways
###end article-title 116
###begin article-title 117
Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation
###end article-title 117
###begin article-title 118
Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence
###end article-title 118
###begin article-title 119
###xml 64 70 <span type="species:ncbi:10090">murine</span>
Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis
###end article-title 119

